Articles related to CLINICAL STUDY

This study emphasizes the potential of MSK1 methylation levels and executive function as key indicators in predicting suicidal ideation among adolescents with major depressive disorder, providing a new dimension to our understanding of suicide risk factors in this age group.

Explore the potential of tDCS as a non-pharmacological intervention for Alzheimer’s disease, demonstrating significant cognitive improvements linked to enhanced cortical plasticity, without serious adverse effects.

This comprehensive study sheds light on the lasting cognitive impacts of COVID-19, revealing that post-infection cognitive deficits can endure beyond a year, significantly affecting memory and executive functions. These findings underscore the importance of long-term cognitive monitoring in COVID-19 survivors.

This longitudinal study offers an unprecedented look at the temporal changes in CSF and imaging biomarkers over two decades, providing clinicians with a detailed timeline of biomarker alterations that precede the clinical onset of Alzheimer’s disease, thereby paving the way for potential early diagnostic and therapeutic strategies.

This study illuminates the potential of preoperative circulating tumor DNA to redefine the approach to treating high-risk upper tract urothelial carcinoma, offering a nuanced tool for assessing the necessity of neoadjuvant chemotherapy and tailoring patient care.

In a recent randomized trial comparing radical and simple hysterectomy in patients with low-risk cervical cancer, findings demonstrated that simple hysterectomy was not inferior in preventing pelvic recurrence at 3 years and offered a significant reduction in postoperative urinary complications.